Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccha

By Shafer D.E.   Toll B.   Schuman R.F.   Nelson B.L.   Mond J.J.   Lees A.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1273-1281

Elsevier

Access to resources Recommend Favorite

Rapid and complete adsorption of unconjugated protein from protein-polysaccharide conjugate vaccines

By Shafer D.E.   Schuman R.F.   Lees A.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1547-1558

Elsevier

Access to resources Recommend Favorite

Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines

By Costantino P.   Norelli F.   Giannozzi A.   D'Ascenzi S.   Bartoloni A.   Kaur S.   Tang D.   Seid R.   Viti S.   Paffetti R.   Bigio M.   Pennatini C.   Averani G.   Guarnieri V.   Gallo E.   Ravenscroft N.   Lazzeroni C.   Rappuoli R.   Ceccarini C.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1251-1263

Elsevier

Access to resources Recommend Favorite

A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines

By Pawlowski A.   Kallenius G.   Svenson S.B.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1474-1483

Elsevier

Access to resources Recommend Favorite

Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines

By Plumb J.E.   Yost S.E.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 399-404

Elsevier

Access to resources Recommend Favorite